Incline Therapeutics, Inc.
Incline Therapeutics, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 2010, the company has made significant strides in developing innovative therapies aimed at improving patient outcomes in pain management and critical care.
Specialising in novel drug delivery systems, Incline Therapeutics is best known for its flagship product, which offers unique advantages in efficacy and safety compared to traditional treatments. The company has established a strong market position, recognised for its commitment to research and development, and has achieved notable milestones in clinical trials.
With a focus on enhancing the quality of care in hospitals and outpatient settings, Incline Therapeutics continues to lead the way in advancing therapeutic solutions that address unmet medical needs.
+73 vs industry average
Incline Therapeutics, Inc.’s score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Incline Therapeutics, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 18% since 2019
Reported emissions
No reported emissions data is available for Incline Therapeutics, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Incline Therapeutics, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Incline Therapeutics, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Novartis AG
Carbon Disclosure Project
Inherited from Novartis AGThe Climate Pledge
Inherited from Novartis AGUN Global Compact Climate Champions initiative
RE 100
Inherited from Novartis AGClimate Action 100
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Incline Therapeutics, Inc. yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project